Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)
ConditionColo-rectal Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40+
SponsorNatera, Inc.
About this trial
The FIND-CRC study is a prospective collection of samples and data from participants who are at average risk of developing colorectal cancer (CRC). Collected samples and data will be analyzed to evaluate the clinical performance of the Natera CRC Screening Test.
Eligibility criteria
Qualifiers
Signed informed consent.
40 years of age or older at the time of consent.
Planning or intending to undergo a standard of care colonoscopy.
Able to tolerate venipuncture for research draw(s).
Disqualifiers
Any prior history of any kind of malignancy (exception: participants who have undergone surgical removal of skin squamous cell or basal cell cancers may be enrolled, provided the procedure was completed at least 12 months prior to consent for the study).
Had a complete colonoscopy with adequate bowel preparation in the previous nine (9) years.
Undergoing diagnostic colonoscopy for the investigation of symptoms.
Up to date with colorectal cancer screening from any non-invasive test.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
25,000 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov